Related Experiment Video
Updated: Jun 4, 2025

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
Out-of-pocket expenditures in hospitalized COVID-19 patients: A systematic review and meta-analysis
Ahmad Dehghani Ahmadabad1, Sayyed Morteza Hosseini Shokouh2, Parisa Mehdizadeh3
1Student Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.
Abstract:
The outbreak of COVID-19 has led to substantial out-of-pocket (OOP) expenditures for households during treatment. This study aimed to investigate the OOP expenditures among hospitalized patients with COVID-19 through a systematic review and meta-analysis. A systematic review and meta-analysis were conducted following the PRISMA guidelines. Articles were retrieved from the PubMed, Scopus, and Google Scholar in the period of 2019-2022 and evaluated for quality using the STROBE guidelines. Homogeneity was assessed using the I2 index, and publication bias was examined using a funnel plot. Meta-analysis was performed using Stata 16. Results of the study have shown that a total of nine articles were included in the meta-analysis. The average OOP expenditure for hospitalized COVID-19 patients was found to be US $308.25 (95% CI: 4.17-620.67). The highest OOP expenditure was reported by CHAU (2021) (US $3171.28), followed by GRAG (2022) (US $1582.38), and the lowest by KOTWANI (2021) (US $56.35). According to the results obtained Significant inequality was observed in the OOP expenditures across different countries. Consistent policy recommendations should be made in international forums to reduce these costs in future pandemics for patients in both developed and developing nations.
More Related Videos
08:36Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
Published on: April 19, 2024
06:16Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
Related Concept Videos
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Hospitals-I
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
Pneumonia III: Complications and Assessment